Sfoglia per Autore
Bornavirus associated with fatal human encephalitis
2015-01-01 Vogrig, A.
Anti-Ma-associated encephalomyeloradiculopathy in a patient with pleural mesothelioma
2015-01-01 Vogrig, A.; Ferrari, S.; Tinazzi, M.; Manganotti, P.; Vattemi, G.; Monaco, S.
Postencephalitic epilepsy in children and adults: Etiology matters
2016-01-01 Vogrig, A.
Nystagmus and lower extremity hyperalgesia after colectomy
2016-01-01 Vogrig, A.; Zanoni, T.; Moretto, G.
Spinal arachnoid cyst as a cause of isolated, progressive, bilateral C5-C6 radiculopathy
2016-01-01 Vogrig, A.; Tonin, P.; Fabrizi, G. M.; Fenzi, F.; Beltramello, A.; Sala, F.; Meglio, M.; Monaco, S.
Prognosis of status epilepticus in adults: recent advances and future directions
2017-01-01 Vogrig, A.; Pauletto, G.
Epidemiology of autoimmune versus infectious encephalitis
2018-01-01 Vogrig, Alberto; Brigo, Francesco; Valente, Mariarosaria; Gigli, Gian Luigi
Probable dysimmune epilepsia partialis continua manifesting as epileptic moving toes syndrome: electroclinical features of a challenging case
2018-01-01 Brigo, F.; Vogrig, A.; Bratti, A.; Tavernelli, V.; Nardone, R.; Trinka, E.
Effect of thymectomy on refractory autoimmune status epilepticus
2018-01-01 Vogrig, Alberto; Pauletto, Giada; Belgrado, Enrico; Pegolo, Enrico; Di Loreto, Carla; Rogemond, Veronique; Honnorat, Jerome; Eleopra, Roberto
NRAS Q61K mutated diffuse leptomeningeal melanomatosis in an adult patient with a brief review of the so-called “forme fruste” of neurocutaneous melanosis
2018-01-01 Girolami, I.; Cima, L.; Ghimenton, C.; Zannoni, M.; Mombello, A.; Riva, G.; Cirielli, V.; Corradi, G.; Vogrig, A.; Di Stefano, G.; Novelli, L.; Gessi, M.; Eccher, A.
Glioblastoma as differential diagnosis of autoimmune encephalitis
2018-01-01 Vogrig, A.; Joubert, B.; Ducray, F.; Thomas, L.; Izquierdo, C.; Decaestecker, K.; Martinaud, O.; Gerardin, E.; Grand, S.; Honnorat, J.
Serum markers as predictors of immune checkpoint inhibitors (ICI) related adverse events in a real-world scenario
2018-01-01 Iacono, D.; Vitale, M. G.; Cortiula, F.; Cinausero, M.; Tullio, A.; Valent, F.; Macerelli, M.; Follador, A.; Vogrig, A.; Minisini, A. M.; Puglisi, F.; Fasola, G.
A systematic study of stereotypy in epileptic seizures versus psychogenic seizure-like events
2019-01-01 Vogrig, A.; Hsiang, J. C.; Ng, J.; Rolnick, J.; Cheng, J.; Parvizi, J.
Increased frequency of anti-Ma2 encephalitis associated with immune checkpoint inhibitors
2019-01-01 Vogrig, A.; Fouret, M.; Joubert, B.; Picard, G.; Rogemond, V.; Pinto, A. -L.; Muniz-Castrillo, S.; Roger, M.; Raimbourg, J.; Dayen, C.; Grignou, L.; Pallix-Guyot, M.; Lannoy, J.; Ducray, F.; Desestret, V.; Psimaras, D.; Honnorat, J.
Motor neuron involvement in anti-Ma2-associated paraneoplastic neurological syndrome
2019-01-01 Vogrig, A.; Joubert, B.; Maureille, A.; Thomas, L.; Bernard, E.; Streichenberger, N.; Cotton, F.; Ducray, F.; Honnorat, J.
Seizure specificities in patients with antibody-mediated autoimmune encephalitis
2019-01-01 Vogrig, A.; Joubert, B.; Andre-Obadia, N.; Gigli, G. L.; Rheims, S.; Honnorat, J.
Peculiar EEG signatures, ictal drinking and long-term follow-up in anti-LGI1 encephalitis
2019-01-01 Vogrig, Alberto; Pauletto, Giada; Lettieri, Christian; Valente, Mariarosaria; Gigli, Gian Luigi
Epilepsia partialis continua revealing idelalisib-associated PML-IRIS: clinical and pathological features
2019-01-01 Vogrig, A.; Gigli, G. L.; Nilo, A.; Pessa, M. E.; Volpetti, S.; Pegolo, E.; Valente, M.
Stroke-Like Presentation of Paraneoplastic Cerebellar Degeneration: a Single-Center Experience and Review of the Literature
2019-01-01 Vogrig, A.; Bernardini, A.; Gigli, G. L.; Corazza, E.; Marini, A.; Segatti, S.; Fabris, M.; Honnorat, J.; Valente, M.
Tacrolimus-induced severe headache associated with diffuse leukoencephalopathy: Evidence for an immune-mediated pathogenesis
2019-01-01 Smeralda, CARMELO LUCA; Gigli, Gian Luigi; Vogrig, Alberto; Marini, Alessandro; Valente, Mariarosaria
Epidemiology of paraneoplastic neurological syndromes: a population-based study
2019-01-01 Vogrig, A.; Gigli, G. L.; Segatti, S.; Corazza, E.; Marini, A.; Bernardini, Andrea; Valent, F.; Fabris, M.; Curcio, F.; Brigo, F.; Iacono, D.; Passadore, P.; Rana, M.; Honnorat, J.; Valente, M.
Stroke in patients with SARS-CoV-2 infection: case series
2020-01-01 Morassi, M.; Bagatto, D.; Cobelli, M.; D'Agostini, S.; Gigli, G. L.; Bna, C.; Vogrig, A.
Central nervous system complications associated with immune checkpoint inhibitors
2020-01-01 Vogrig, A.; Muniz-Castrillo, S.; Joubert, B.; Picard, G.; Rogemond, V.; Marchal, C.; Chiappa, A. M.; Chanson, E.; Skowron, F.; Leblanc, A.; Ducray, F.; Honnorat, J.
Associations between HLA and autoimmune neurological diseases with autoantibodies
2020-01-01 Muniz-Castrillo, S.; Vogrig, A.; Honnorat, J.
Stroke in patients with COVID-19: Clinical and neuroimaging characteristics
2020-01-01 Vogrig, A.; Gigli, G. L.; Bna, C.; Morassi, M.
Bilateral carotid artery dissection in a SARS-CoV-2 infected patient: causality or coincidence?
2020-01-01 Morassi, M.; Bigni, B.; Cobelli, M.; Giudice, L.; Bnà, C.; Vogrig, A.
Anti-CASPR2 clinical phenotypes correlate with HLA and immunological features
2020-01-01 Muniz-Castrillo, S.; Joubert, B.; Elsensohn, M. -H.; Pinto, A. -L.; Saint-Martin, M.; Vogrig, A.; Picard, G.; Rogemond, V.; Dubois, V.; Tamouza, R.; Maucort-Boulch, D.; Honnorat, J.
Diagnostic yield of commercial immunodots to diagnose paraneoplastic neurologic syndromes
2020-01-01 Déchelotte, B.; Muniz-Castrillo, S.; Joubert, B.; Vogrig, A.; Picard, G.; Rogemond, V.; Pinto, A-L.; Lombard, C.; Desestret, V.; Fabien, N.; Honnorat, J.
Clinical spectrum and diagnostic pitfalls of neurologic syndromes with Ri antibodies
2020-01-01 Simard, C.; Vogrig, A.; Joubert, B.; Muniz-Castrillo, S.; Picard, G.; Rogemond, V.; Ducray, F.; Berzero, G.; Psimaras, D.; Antoine, J. -C.; Desestret, V.; Honnorat, J.
Pathophysiology of paraneoplastic and autoimmune encephalitis: genes, infections, and checkpoint inhibitors
2020-01-01 Vogrig, A.; Muniz-Castrillo, S.; Desestret, V.; Joubert, B.; Honnorat, J.
Value of Onconeural Antibodies in Checkpoint Inhibitor-Related Toxicities
2020-01-01 Vogrig, A.; Muniz-Castrillo, S.; Honnorat, J.
HLA and immunological features of SARS-CoV-2-induced Guillain-Barré syndrome
2020-01-01 Gigli, G. L.; Vogrig, A.; Nilo, A.; Fabris, M.; Biasotto, A.; Curcio, F.; Miotti, V.; Tascini, C.; Valente, M.
Perampanel as add-on therapy in epilepsies with known etiology: A single center experience with long-term follow-up
2020-01-01 Nilo, Annacarmen; Pauletto, Giada; Gigli, Gian Luigi; Vogrig, Alberto; Dolso, Pierluigi; Valente, Mariarosaria
Diagnosis of autoimmune encephalitides: An update
2020-01-01 Muniz-Castrillo, S.; Joubert, B.; Vogrig, A.; Honnorat, J.
Transient Neurological Symptoms Preceding Cerebellar Ataxia with Glutamic Acid Decarboxylase Antibodies
2020-01-01 Muniz-Castrillo, S.; Vogrig, A.; Joubert, B.; Pinto, A. -L.; Goncalves, D.; Chaumont, H.; Rogemond, V.; Picard, G.; Fabien, N.; Honnorat, J.
Primary DQ effect in the association between HLA and neurological syndromes with anti-GAD65 antibodies
2020-01-01 Muniz-Castrillo, S.; Ambati, A.; Dubois, V.; Vogrig, A.; Joubert, B.; Rogemond, V.; Picard, G.; Lin, L.; Fabien, N.; Mignot, E.; Honnorat, J.
Reply to "Guillain‑Barré syndrome in the COVID‑19 era another occasional cluster?": Insights from two distinct clusters of Guillain–Barré syndrome detected in Europe in the COVID-19 era
2020-01-01 Marini, A.; Vogrig, A.; Bax, F.; Pellitteri, G.; Surcinelli, A.; Valente, M.; Gigli, G. L.
Anti-Hu-associated paraneoplastic syndromes triggered by immune-checkpoint inhibitor treatment
2020-01-01 Mongay-Ochoa, N.; Vogrig, A.; Muniz-Castrillo, S.; Honnorat, J.
Causality in COVID-19-associated stroke: a uniform case definition for use in clinical research
2020-01-01 Vogrig, A.; Bagatto, D.; Gigli, G. L.; Cobelli, M.; D'Agostini, S.; Bna, C.; Morassi, M.
Epidemiology of paraneoplastic neurologic syndromes and autoimmune encephalitides in France
2020-01-01 Hébert, J.; Riche, B.; Vogrig, A.; Muniz-Castrillo, S.; Joubert, B.; Picard, G.; Rogemond, V.; Psimaras, D.; Alentorn, A.; Berzero, G.; Desestret, V.; Rabilloud, M.; Honnorat, J.
Reader Response: Prolonged Unconsciousness Following Severe COVID-19
2021-01-01 Vogrig, Alberto; Valente, Mariarosaria; Nilo, Annacarmen; Gigli, Gian Luigi
Unclear association between COVID-19 and Guillain-Barré syndrome
2021-01-01 Vogrig, Alberto; Moritz, Christian P; Camdessanché, Jean-Philippe; Tholance, Yannick; Antoine, Jean-Christophe; Honnorat, Jérôme; Gigli, Gian Luigi
Neurologic Adverse Events of Immune Checkpoint Inhibitors: A Systematic Review
2021-01-01 Marini, Alessandro; Bernardini, Andrea; Gigli, Gian Luigi; Valente, Mariarosaria; Muñiz-Castrillo, Sergio; Honnorat, Jérôme; Vogrig, Alberto
Familial autoimmunity in neurological patients with GAD65 antibodies: an interview-based study
2021-01-01 Muniz-Castrillo, S.; Vogrig, A.; Montagnac, C.; Joubert, B.; Benaiteau, M.; Casez, O.; Chaumont, H.; Hopes, L.; Lanoiselee, H. -M.; Navarro, V.; Thomas, B.; Ursu, R.; Goncalves, D.; Fabien, N.; Ducray, F.; Julier, C.; Honnorat, J.
Updated Diagnostic Criteria for Paraneoplastic Neurologic Syndromes
2021-01-01 Graus, F.; Vogrig, A.; Muniz-Castrillo, S.; Antoine, J. -C. G.; Desestret, V.; Dubey, D.; Giometto, B.; Irani, S. R.; Joubert, B.; Leypoldt, F.; Mckeon, A.; Pruss, H.; Psimaras, D.; Thomas, L.; Titulaer, M. J.; Vedeler, C. A.; Verschuuren, J. J.; Dalmau, J.; Honnorat, J.
18F-FDG PET brain findings in disease-discordant monozygotic mosaic twins with Cri du Chat (5p-) syndrome
2021-01-01 Cistaro, A.; Schiera, I. G.; Fania, P.; Tognon, F.; Liava, A.; Danesino, C.; Albani, G.; Guala, A.; Vogrig, A.; Quartuccio, N.
Cranial Nerve Disorders Associated With Immune Checkpoint Inhibitors
2021-01-01 Vogrig, A.; Muniz-Castrillo, S.; Joubert, B.; Picard, G.; Rogemond, V.; Skowron, F.; Egri, M.; Desestret, V.; Tilikete, C.; Psimaras, D.; Ducray, F.; Honnorat, J.
Role of LGI1 protein in synaptic transmission: From physiology to pathology
2021-01-01 Fels, E.; Muniz-Castrillo, S.; Vogrig, A.; Joubert, B.; Honnorat, J.; Pascual, O.
Immunopathogenesis and proposed clinical score for identifying Kelch-like protein-11 encephalitis
2021-01-01 Vogrig, A.; Péricart, S.; Pinto, A-L.; Rogemond, V.; Muniz-Castrillo, S.; Picard, G.; Selton, M.; Mittelbronn, M.; Lanoiselée, H-M.; Michenet, P.; Benaiteau, M.; Pariente, J.; Zéphir, H.; Giordana, C.; Montaut, S.; Salhi, H.; Bachoumas, P.; Montcuquet, A.; Letovanec, I.; Uro-Coste, E.; Honnorat, J.
Clinical and Prognostic Value of Immunogenetic Characteristics in Anti-LGI1 Encephalitis
2021-01-01 Muniz-Castrillo, S.; Haesebaert, J.; Thomas, L.; Vogrig, A.; Pinto, A. -L.; Picard, G.; Blanc, C.; Do, L. -D.; Joubert, B.; Berzero, G.; Psimaras, D.; Alentorn, A.; Rogemond, V.; Dubois, V.; Ambati, A.; Tamouza, R.; Mignot, E.; Honnorat, J.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Bornavirus associated with fatal human encephalitis | 1-gen-2015 | Vogrig, A. | |
| Anti-Ma-associated encephalomyeloradiculopathy in a patient with pleural mesothelioma | 1-gen-2015 | Vogrig, A.; Ferrari, S.; Tinazzi, M.; Manganotti, P.; Vattemi, G.; Monaco, S. | |
| Postencephalitic epilepsy in children and adults: Etiology matters | 1-gen-2016 | Vogrig, A. | |
| Nystagmus and lower extremity hyperalgesia after colectomy | 1-gen-2016 | Vogrig, A.; Zanoni, T.; Moretto, G. | |
| Spinal arachnoid cyst as a cause of isolated, progressive, bilateral C5-C6 radiculopathy | 1-gen-2016 | Vogrig, A.; Tonin, P.; Fabrizi, G. M.; Fenzi, F.; Beltramello, A.; Sala, F.; Meglio, M.; Monaco, S. | |
| Prognosis of status epilepticus in adults: recent advances and future directions | 1-gen-2017 | Vogrig, A.; Pauletto, G. | |
| Epidemiology of autoimmune versus infectious encephalitis | 1-gen-2018 | Vogrig, Alberto; Brigo, Francesco; Valente, Mariarosaria; Gigli, Gian Luigi | |
| Probable dysimmune epilepsia partialis continua manifesting as epileptic moving toes syndrome: electroclinical features of a challenging case | 1-gen-2018 | Brigo, F.; Vogrig, A.; Bratti, A.; Tavernelli, V.; Nardone, R.; Trinka, E. | |
| Effect of thymectomy on refractory autoimmune status epilepticus | 1-gen-2018 | Vogrig, Alberto; Pauletto, Giada; Belgrado, Enrico; Pegolo, Enrico; Di Loreto, Carla; Rogemond, Veronique; Honnorat, Jerome; Eleopra, Roberto | |
| NRAS Q61K mutated diffuse leptomeningeal melanomatosis in an adult patient with a brief review of the so-called “forme fruste” of neurocutaneous melanosis | 1-gen-2018 | Girolami, I.; Cima, L.; Ghimenton, C.; Zannoni, M.; Mombello, A.; Riva, G.; Cirielli, V.; Corradi, G.; Vogrig, A.; Di Stefano, G.; Novelli, L.; Gessi, M.; Eccher, A. | |
| Glioblastoma as differential diagnosis of autoimmune encephalitis | 1-gen-2018 | Vogrig, A.; Joubert, B.; Ducray, F.; Thomas, L.; Izquierdo, C.; Decaestecker, K.; Martinaud, O.; Gerardin, E.; Grand, S.; Honnorat, J. | |
| Serum markers as predictors of immune checkpoint inhibitors (ICI) related adverse events in a real-world scenario | 1-gen-2018 | Iacono, D.; Vitale, M. G.; Cortiula, F.; Cinausero, M.; Tullio, A.; Valent, F.; Macerelli, M.; Follador, A.; Vogrig, A.; Minisini, A. M.; Puglisi, F.; Fasola, G. | |
| A systematic study of stereotypy in epileptic seizures versus psychogenic seizure-like events | 1-gen-2019 | Vogrig, A.; Hsiang, J. C.; Ng, J.; Rolnick, J.; Cheng, J.; Parvizi, J. | |
| Increased frequency of anti-Ma2 encephalitis associated with immune checkpoint inhibitors | 1-gen-2019 | Vogrig, A.; Fouret, M.; Joubert, B.; Picard, G.; Rogemond, V.; Pinto, A. -L.; Muniz-Castrillo, S.; Roger, M.; Raimbourg, J.; Dayen, C.; Grignou, L.; Pallix-Guyot, M.; Lannoy, J.; Ducray, F.; Desestret, V.; Psimaras, D.; Honnorat, J. | |
| Motor neuron involvement in anti-Ma2-associated paraneoplastic neurological syndrome | 1-gen-2019 | Vogrig, A.; Joubert, B.; Maureille, A.; Thomas, L.; Bernard, E.; Streichenberger, N.; Cotton, F.; Ducray, F.; Honnorat, J. | |
| Seizure specificities in patients with antibody-mediated autoimmune encephalitis | 1-gen-2019 | Vogrig, A.; Joubert, B.; Andre-Obadia, N.; Gigli, G. L.; Rheims, S.; Honnorat, J. | |
| Peculiar EEG signatures, ictal drinking and long-term follow-up in anti-LGI1 encephalitis | 1-gen-2019 | Vogrig, Alberto; Pauletto, Giada; Lettieri, Christian; Valente, Mariarosaria; Gigli, Gian Luigi | |
| Epilepsia partialis continua revealing idelalisib-associated PML-IRIS: clinical and pathological features | 1-gen-2019 | Vogrig, A.; Gigli, G. L.; Nilo, A.; Pessa, M. E.; Volpetti, S.; Pegolo, E.; Valente, M. | |
| Stroke-Like Presentation of Paraneoplastic Cerebellar Degeneration: a Single-Center Experience and Review of the Literature | 1-gen-2019 | Vogrig, A.; Bernardini, A.; Gigli, G. L.; Corazza, E.; Marini, A.; Segatti, S.; Fabris, M.; Honnorat, J.; Valente, M. | |
| Tacrolimus-induced severe headache associated with diffuse leukoencephalopathy: Evidence for an immune-mediated pathogenesis | 1-gen-2019 | Smeralda, CARMELO LUCA; Gigli, Gian Luigi; Vogrig, Alberto; Marini, Alessandro; Valente, Mariarosaria | |
| Epidemiology of paraneoplastic neurological syndromes: a population-based study | 1-gen-2019 | Vogrig, A.; Gigli, G. L.; Segatti, S.; Corazza, E.; Marini, A.; Bernardini, Andrea; Valent, F.; Fabris, M.; Curcio, F.; Brigo, F.; Iacono, D.; Passadore, P.; Rana, M.; Honnorat, J.; Valente, M. | |
| Stroke in patients with SARS-CoV-2 infection: case series | 1-gen-2020 | Morassi, M.; Bagatto, D.; Cobelli, M.; D'Agostini, S.; Gigli, G. L.; Bna, C.; Vogrig, A. | |
| Central nervous system complications associated with immune checkpoint inhibitors | 1-gen-2020 | Vogrig, A.; Muniz-Castrillo, S.; Joubert, B.; Picard, G.; Rogemond, V.; Marchal, C.; Chiappa, A. M.; Chanson, E.; Skowron, F.; Leblanc, A.; Ducray, F.; Honnorat, J. | |
| Associations between HLA and autoimmune neurological diseases with autoantibodies | 1-gen-2020 | Muniz-Castrillo, S.; Vogrig, A.; Honnorat, J. | |
| Stroke in patients with COVID-19: Clinical and neuroimaging characteristics | 1-gen-2020 | Vogrig, A.; Gigli, G. L.; Bna, C.; Morassi, M. | |
| Bilateral carotid artery dissection in a SARS-CoV-2 infected patient: causality or coincidence? | 1-gen-2020 | Morassi, M.; Bigni, B.; Cobelli, M.; Giudice, L.; Bnà, C.; Vogrig, A. | |
| Anti-CASPR2 clinical phenotypes correlate with HLA and immunological features | 1-gen-2020 | Muniz-Castrillo, S.; Joubert, B.; Elsensohn, M. -H.; Pinto, A. -L.; Saint-Martin, M.; Vogrig, A.; Picard, G.; Rogemond, V.; Dubois, V.; Tamouza, R.; Maucort-Boulch, D.; Honnorat, J. | |
| Diagnostic yield of commercial immunodots to diagnose paraneoplastic neurologic syndromes | 1-gen-2020 | Déchelotte, B.; Muniz-Castrillo, S.; Joubert, B.; Vogrig, A.; Picard, G.; Rogemond, V.; Pinto, A-L.; Lombard, C.; Desestret, V.; Fabien, N.; Honnorat, J. | |
| Clinical spectrum and diagnostic pitfalls of neurologic syndromes with Ri antibodies | 1-gen-2020 | Simard, C.; Vogrig, A.; Joubert, B.; Muniz-Castrillo, S.; Picard, G.; Rogemond, V.; Ducray, F.; Berzero, G.; Psimaras, D.; Antoine, J. -C.; Desestret, V.; Honnorat, J. | |
| Pathophysiology of paraneoplastic and autoimmune encephalitis: genes, infections, and checkpoint inhibitors | 1-gen-2020 | Vogrig, A.; Muniz-Castrillo, S.; Desestret, V.; Joubert, B.; Honnorat, J. | |
| Value of Onconeural Antibodies in Checkpoint Inhibitor-Related Toxicities | 1-gen-2020 | Vogrig, A.; Muniz-Castrillo, S.; Honnorat, J. | |
| HLA and immunological features of SARS-CoV-2-induced Guillain-Barré syndrome | 1-gen-2020 | Gigli, G. L.; Vogrig, A.; Nilo, A.; Fabris, M.; Biasotto, A.; Curcio, F.; Miotti, V.; Tascini, C.; Valente, M. | |
| Perampanel as add-on therapy in epilepsies with known etiology: A single center experience with long-term follow-up | 1-gen-2020 | Nilo, Annacarmen; Pauletto, Giada; Gigli, Gian Luigi; Vogrig, Alberto; Dolso, Pierluigi; Valente, Mariarosaria | |
| Diagnosis of autoimmune encephalitides: An update | 1-gen-2020 | Muniz-Castrillo, S.; Joubert, B.; Vogrig, A.; Honnorat, J. | |
| Transient Neurological Symptoms Preceding Cerebellar Ataxia with Glutamic Acid Decarboxylase Antibodies | 1-gen-2020 | Muniz-Castrillo, S.; Vogrig, A.; Joubert, B.; Pinto, A. -L.; Goncalves, D.; Chaumont, H.; Rogemond, V.; Picard, G.; Fabien, N.; Honnorat, J. | |
| Primary DQ effect in the association between HLA and neurological syndromes with anti-GAD65 antibodies | 1-gen-2020 | Muniz-Castrillo, S.; Ambati, A.; Dubois, V.; Vogrig, A.; Joubert, B.; Rogemond, V.; Picard, G.; Lin, L.; Fabien, N.; Mignot, E.; Honnorat, J. | |
| Reply to "Guillain‑Barré syndrome in the COVID‑19 era another occasional cluster?": Insights from two distinct clusters of Guillain–Barré syndrome detected in Europe in the COVID-19 era | 1-gen-2020 | Marini, A.; Vogrig, A.; Bax, F.; Pellitteri, G.; Surcinelli, A.; Valente, M.; Gigli, G. L. | |
| Anti-Hu-associated paraneoplastic syndromes triggered by immune-checkpoint inhibitor treatment | 1-gen-2020 | Mongay-Ochoa, N.; Vogrig, A.; Muniz-Castrillo, S.; Honnorat, J. | |
| Causality in COVID-19-associated stroke: a uniform case definition for use in clinical research | 1-gen-2020 | Vogrig, A.; Bagatto, D.; Gigli, G. L.; Cobelli, M.; D'Agostini, S.; Bna, C.; Morassi, M. | |
| Epidemiology of paraneoplastic neurologic syndromes and autoimmune encephalitides in France | 1-gen-2020 | Hébert, J.; Riche, B.; Vogrig, A.; Muniz-Castrillo, S.; Joubert, B.; Picard, G.; Rogemond, V.; Psimaras, D.; Alentorn, A.; Berzero, G.; Desestret, V.; Rabilloud, M.; Honnorat, J. | |
| Reader Response: Prolonged Unconsciousness Following Severe COVID-19 | 1-gen-2021 | Vogrig, Alberto; Valente, Mariarosaria; Nilo, Annacarmen; Gigli, Gian Luigi | |
| Unclear association between COVID-19 and Guillain-Barré syndrome | 1-gen-2021 | Vogrig, Alberto; Moritz, Christian P; Camdessanché, Jean-Philippe; Tholance, Yannick; Antoine, Jean-Christophe; Honnorat, Jérôme; Gigli, Gian Luigi | |
| Neurologic Adverse Events of Immune Checkpoint Inhibitors: A Systematic Review | 1-gen-2021 | Marini, Alessandro; Bernardini, Andrea; Gigli, Gian Luigi; Valente, Mariarosaria; Muñiz-Castrillo, Sergio; Honnorat, Jérôme; Vogrig, Alberto | |
| Familial autoimmunity in neurological patients with GAD65 antibodies: an interview-based study | 1-gen-2021 | Muniz-Castrillo, S.; Vogrig, A.; Montagnac, C.; Joubert, B.; Benaiteau, M.; Casez, O.; Chaumont, H.; Hopes, L.; Lanoiselee, H. -M.; Navarro, V.; Thomas, B.; Ursu, R.; Goncalves, D.; Fabien, N.; Ducray, F.; Julier, C.; Honnorat, J. | |
| Updated Diagnostic Criteria for Paraneoplastic Neurologic Syndromes | 1-gen-2021 | Graus, F.; Vogrig, A.; Muniz-Castrillo, S.; Antoine, J. -C. G.; Desestret, V.; Dubey, D.; Giometto, B.; Irani, S. R.; Joubert, B.; Leypoldt, F.; Mckeon, A.; Pruss, H.; Psimaras, D.; Thomas, L.; Titulaer, M. J.; Vedeler, C. A.; Verschuuren, J. J.; Dalmau, J.; Honnorat, J. | |
| 18F-FDG PET brain findings in disease-discordant monozygotic mosaic twins with Cri du Chat (5p-) syndrome | 1-gen-2021 | Cistaro, A.; Schiera, I. G.; Fania, P.; Tognon, F.; Liava, A.; Danesino, C.; Albani, G.; Guala, A.; Vogrig, A.; Quartuccio, N. | |
| Cranial Nerve Disorders Associated With Immune Checkpoint Inhibitors | 1-gen-2021 | Vogrig, A.; Muniz-Castrillo, S.; Joubert, B.; Picard, G.; Rogemond, V.; Skowron, F.; Egri, M.; Desestret, V.; Tilikete, C.; Psimaras, D.; Ducray, F.; Honnorat, J. | |
| Role of LGI1 protein in synaptic transmission: From physiology to pathology | 1-gen-2021 | Fels, E.; Muniz-Castrillo, S.; Vogrig, A.; Joubert, B.; Honnorat, J.; Pascual, O. | |
| Immunopathogenesis and proposed clinical score for identifying Kelch-like protein-11 encephalitis | 1-gen-2021 | Vogrig, A.; Péricart, S.; Pinto, A-L.; Rogemond, V.; Muniz-Castrillo, S.; Picard, G.; Selton, M.; Mittelbronn, M.; Lanoiselée, H-M.; Michenet, P.; Benaiteau, M.; Pariente, J.; Zéphir, H.; Giordana, C.; Montaut, S.; Salhi, H.; Bachoumas, P.; Montcuquet, A.; Letovanec, I.; Uro-Coste, E.; Honnorat, J. | |
| Clinical and Prognostic Value of Immunogenetic Characteristics in Anti-LGI1 Encephalitis | 1-gen-2021 | Muniz-Castrillo, S.; Haesebaert, J.; Thomas, L.; Vogrig, A.; Pinto, A. -L.; Picard, G.; Blanc, C.; Do, L. -D.; Joubert, B.; Berzero, G.; Psimaras, D.; Alentorn, A.; Rogemond, V.; Dubois, V.; Ambati, A.; Tamouza, R.; Mignot, E.; Honnorat, J. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile